Xycota is advancing a transformative biological interface designed to physically repair damaged neural networks in catastrophic neurodegenerative diseases. This paradigm-shifting approach decouples therapeutic neural restoration from psychedelic side effects, establishing a standardized, controllable mechanism for structural brain repair. About Xycota Biosciences, LLCXycota Biosciences, LLC is a precision biotechnology company engineering exosome-delivered neuroplasticity therapeutics to repair brain circuitry. About NexTel Medical Corp.NexTel Medical Corp. is a medical technology and biotechnology enterprise focused on acquiring, integrating, and commercializing high-impact medical platforms, novel therapeutic delivery technologies, and healthcare innovations. Media & Investor Contacts:NexTel Medical Corp.Investor Relations & Corporate CommunicationsEmail: ir@nextelmedical.comWebsite: www.nextelmedical.comXycota Biosciences, LLCBrad Listermann, President & Co-FounderEmail: info@xycota.comWebsite: https://xycota.com/SOURCE: NexTel Medical CorpView the original press release on ACCESS Newswire:https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/nextel-medical-corp.-executes-letter-of-intent-to-acquire-100-of-xyco-1201772